A new kind of cancer test could soon change how doctors detect deadly diseases—quickly, cheaply, and almost anywhere. A team of researchers has designed a small, low-cost device that can ...

Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad range of cancers with high accuracy using cell-free DNA. A multi-cancer ...

A deep learning approach allows CT images to be compared automatically in the context of cancer treatment—so that even small changes to lung tumors can be detected and located with greater speed ...

10542Background: Emerging liquid biopsy multi-cancer early detection (MCED) tests have the potential to revolutionize early cancer detection. Using a simulation model, we estimated their impact on ...

Methods: Recent advancements in deep learning have significantly improved medical image analysis, demonstrating superior predictive performance in breast cancer detection using ultrasound images.

National radiology network Radnet to acquire iCAD for over $100 million for its breast cancer screening AI algorithm.

Early detection is essential for better outcomes, but traditional CT image analysis is time-consuming, prone to error, and relies on subjective judgments. To overcome these issues, we propose a custom ...

Lung cancer is one of the fatal diseases whose early diagnosis is essential to mitigate the death rate. Computed Tomography (CT) scans are widely used for lung cancer diagnosis, but manual ...

Researchers have created a new type of AI cancer detection that can detect a hard-to-spot cancer much earlier with 99% accuracy.

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms ...

Breast cancer is an increasingly serious problem in contemporary society, with millions of women and men worldwide affected by the disease. While traditional cancer detection strategies are at times ...

AI-powered analysis of multianalyte liquid biopsies could be an accessible way to improve ovarian cancer screening.